Details of the Drug Reposition

General Information of This Drug (ID: DMG7I5J)

Drug Name	DS-3078 DMG7I5J

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
Lymphoma	DISN6V4S	2A80-2A86	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01588678) A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas. U.S. National Institutes of Health.